Author:
Stebbing Justin,Jones Alison,Barrett-Lee Peter
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Buja LM, Ferrans VJ, Mayer RJ, Roberts WC, Henderson ES (1973) Cardiac ultrastructural changes induced by daunorubicin therapy. Cancer 32:771–788
2. Al-Ismail SA, Parry DH, Whittaker JA (1977) Anthracycline cardiotoxicity and acute myelogenous leukaemia. Br Med J 1:815
3. Marni E, Marchi A, Laini C, Zanol MG, Martini A, Livieri C, Genova R (1978) Studies on the cardiotoxicity of daunomycin in patients with acute leukemia. Minerva Pediatr 30:333–338
4. Perez DJ, Harvey VJ, Robinson BA, Atkinson CH, Dady PJ, Kirk AR, Evans BD, Chapman PJ (1991) A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer. J Clin Oncol 9:2148–2152
5. Tan-Chiu E, Yothers G, Romond E, Geyer CE Jr., Ewer M, Keefe D, Shannon RP, Swain SM, Brown A, Fehrenbacher L, Vogel VG, Seay TE, Rastogi P, Mamounas EP, Wolmark N, Bryant J (2005) Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31. J Clin Oncol 23:7811–7819
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献